Frisch, A. et al. 2026. Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy. Journal of Medical Cases. 17, 1 (Jan. 2026), 28–31. DOI:https://doi.org/10.14740/jmc5211.